CPRX vs. CL
Compare and contrast key facts about Catalyst Pharmaceuticals, Inc. (CPRX) and Colgate-Palmolive Company (CL).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: CPRX or CL.
Key characteristics
| CPRX | CL | |
|---|---|---|
| YTD Return | -10.65% | 17.94% |
| 1Y Return | -9.52% | 17.19% |
| 3Y Return (Ann) | 45.63% | 7.22% |
| 5Y Return (Ann) | 19.94% | 7.80% |
| 10Y Return (Ann) | 22.32% | 5.79% |
| Sharpe Ratio | -0.20 | 1.26 |
| Daily Std Dev | 48.05% | 14.13% |
| Max Drawdown | -94.25% | -67.62% |
| Current Drawdown | -28.65% | 0.00% |
Fundamentals
| CPRX | CL | |
|---|---|---|
| Market Cap | $1.76B | $74.81B |
| EPS | $0.63 | $2.77 |
| PE Ratio | 23.63 | 32.86 |
| PEG Ratio | 0.00 | 2.15 |
| Revenue (TTM) | $398.20M | $19.75B |
| Gross Profit (TTM) | $160.02M | $10.25B |
| EBITDA (TTM) | $119.69M | $4.70B |
Correlation
The correlation between CPRX and CL is 0.08, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
CPRX vs. CL - Performance Comparison
In the year-to-date period, CPRX achieves a -10.65% return, which is significantly lower than CL's 17.94% return. Over the past 10 years, CPRX has outperformed CL with an annualized return of 22.32%, while CL has yielded a comparatively lower 5.79% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
CPRX vs. CL - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Catalyst Pharmaceuticals, Inc. (CPRX) and Colgate-Palmolive Company (CL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
CPRX vs. CL - Dividend Comparison
CPRX has not paid dividends to shareholders, while CL's dividend yield for the trailing twelve months is around 2.09%.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CPRX Catalyst Pharmaceuticals, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
CL Colgate-Palmolive Company | 2.09% | 2.40% | 2.36% | 2.10% | 2.05% | 2.48% | 2.79% | 2.11% | 2.37% | 2.25% | 2.05% | 2.04% |
Drawdowns
CPRX vs. CL - Drawdown Comparison
The maximum CPRX drawdown since its inception was -94.25%, which is greater than CL's maximum drawdown of -67.62%. Use the drawdown chart below to compare losses from any high point for CPRX and CL. For additional features, visit the drawdowns tool.
Volatility
CPRX vs. CL - Volatility Comparison
Catalyst Pharmaceuticals, Inc. (CPRX) has a higher volatility of 9.81% compared to Colgate-Palmolive Company (CL) at 3.69%. This indicates that CPRX's price experiences larger fluctuations and is considered to be riskier than CL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
CPRX vs. CL - Financials Comparison
This section allows you to compare key financial metrics between Catalyst Pharmaceuticals, Inc. and Colgate-Palmolive Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities